Market Tracker

06/24 5:16pm ET

Allergan plc (NYSE:AGN)

225.72
Delayed Data
As of Jun 24
 -7.79 / -3.34%
Today’s Change
195.50
Today|||52-Week Range
340.34
-27.77%
Year-to-Date
3 of Paul Singer's Top 5 Deals in 1st Quarter Involve Technology Stocks
9:18am / GuruFocus News - Paid Partner Content
Why Pfizer (PFE) is a Great Stock to Buy for the Long Run
Jun 23 / Zacks.com - Paid Partner Content
Steve Mandel Exits Position in Williams Companies in 1st Quarter
Jun 24 / GuruFocus News - Paid Partner Content
Better Buy: Valeant Pharmaceuticals International, Inc. vs. Allergan
Jun 23 / MotleyFool.com - Paid Partner Content
Brexit Sell-Off Hits 3 Big Pharma Bargain Stocks
Jun 24 / MotleyFool.com - Paid Partner Content
Cross Signs Flashing 'Watch and Wait'
Jun 23 / TheStreet.com - Paid Partner Content
Allergan Is Primed for Increase After a Big Decline
Jun 24 / TheStreet.com - Paid Partner Content
Jim Cramer's 'Mad Money' Recap: We Need More Mergers Right Now
Jun 22 / TheStreet.com - Paid Partner Content
Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
Jun 24 / Zacks.com - Paid Partner Content
Impax (IPXL) Stock Declines on Deal to Buy Generic Products
Jun 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close233.51
Today’s open226.49
Day’s range225.40 - 229.82
Volume4,329,900
Average volume (3 months)4,675,984
Market cap$91.6B
Dividend yield--
Data as of 4:03pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+5.44%
Earnings growth (next 5 years)+13.20%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.27

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-1.45-2.37%
GSKGlaxoSmithKline-1.76-4.14%
NVONovo Nordisk-2.34-4.38%
LLYEli Lilly and Co+0.39+0.53%
Data as of 4:06pm ET, 06/24/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$3.36
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts